San Antonio student Neha Hariharaprasad has won Texas's 20th Congressional District's Congressional App Challenge with her ...

The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

Self-guided cognitive behavioral therapy (CBT) proved noninferior to clinician-guided CBT for reducing symptom severity in ...

Medically reviewed by Susan Bard, MD Vulvar dermatitis is a skin condition that affects the skin of the vulva. The vulva is ...

For some people, keeping up with eczema treatments can be difficult, but resources are available to help find relief from the ...

Castle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile Test ...

Andrew Rosenberg, DVM, and Adam Christman, DVM, MBA, talk about shortcomings of treatments approved for canine allergic and ...

The FDA has approved Vtama® (tapinarof) cream 1% for the topical treatment of atopic dermatitis in patients aged 2 years and older.

The global hand eczema treatment market is projected to experience robust growth, with a market value of USD 53 million in ...

A new study from Karolinska Institutet shows that self-guided cognitive behavioral therapy (CBT) online is as effective as ...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and that the study is actively enrolling patients. AD ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.